Bionano Genomics (BNGO) Assets Average (2018 - 2026)

Bionano Genomics has disclosed Assets Average across 9 years of filings, most recently posting $56.2 million for Q2 2026.

• In Q2 2026, Assets Average fell 27.22% year-over-year to $56.2 million; the TTM figure through Jun 2026 stood at $56.2 million (down 27.22% YoY), while the FY2025 annual figure was $75.1 million, down 48.38% from the prior year.
• Assets Average came in at $56.2 million for Q2 2026 at Bionano Genomics, down from $69.2 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $362.7 million in Q1 2022 to a low of $56.2 million in Q2 2026.
• Average Assets Average over 5 years is $183.1 million, with a median of $164.9 million recorded in 2024.
• Year-over-year, Assets Average soared 62.88% in 2022 and plunged 58.61% in 2024.
• Over 5 years, Assets Average stood at $315.6 million in 2022, then tumbled by 37.21% to $198.2 million in 2023, then slumped by 58.61% to $82.0 million in 2024, then declined by 6.94% to $76.3 million in 2025, then retreated by 26.37% to $56.2 million in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $56.2 million in Q2 2026, $69.2 million in Q1 2026, and $76.3 million in Q4 2025.